The latest trading session saw Viking Therapeutics, Inc. (VKTX) ending at $54.78, denoting a +1.2% adjustment from its last day's close. This move outpaced the S&P 500's daily gain of 1.16%. Elsewhere, the Dow gained 1.2%, while the tech-heavy Nasdaq added 1.16%. The company's stock has dropped by 5.3% in the past month, falling short of the Medical sector's gain of 4.5% and the S&P 500's gain of 3.48%. The upcoming earnings release of Viking Therapeutics, Inc. will be of great interest to investors. The co ...